-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 22, Roche released the 2021 semi-annual report, with total revenue of 30.
Roche's heavyweight bispecific antibody Hemlibra (imicelizumab) has covered all types of hemophilia patients.
Attached table: Sales of Roche's main products in 2020 (100 million Swiss francs)
Original title: Roche's 2021 semi-annual report: revenue of 30.
7 billion Swiss francs, China's 2.
9 billion Swiss francs, PD-L1 increased by 29%, and Iimerizumab increased by 45%